Stay updated on ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Sign up to get notified when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.

Latest updates to the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page
- Check2 days agoChange DetectedA new revision entry v3.5.4 appears on 2026-05-08 with the Study Status item and the marker 118, while the previous revision v3.5.3 (2026-04-13) is removed from the history.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry, v3.5.3, has been added to the history. The older revision v3.5.2 has been removed.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedAdded a new 'Study Status' entry to the record history (Version 117, Revision v3.5.2) dated 2026-04-13.SummaryDifference0.2%

- Check52 days agoChange DetectedNew history entry on 2026-03-19 shows a Study Status update (version 116) corresponding to 2026-03-18; the 2026-02-13 entry was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded revision entry v3.5.0 and removed revision v3.4.3 from the record history.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page footer now shows Revision: v3.4.3 instead of v3.4.2. This is a minor site update and does not change the study data or visible page content.SummaryDifference0.0%

Stay in the know with updates to ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.